Influence of coding variability in APP-Aβ metabolism genes in sporadic Alzheimer's disease

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Sassi, Celeste ^a,b,c,d   Ridge, Perry G ^e   Nalls, Michael A ^b   Gibbs, Raphael ^b   Ding, Jinhui ^b   Lupton, Michelle K ^f,g   Troakes, Claire ^f   Lunnon, Katie ^f   Al Sarraj, Safa ^f   Brown, Kristelle S ^h   Medway, Christopher ^h   Lord, Jenny ^h   Turton, James ^h   Morgan, Kevin ^h   Powell, John F ^f   Kauwe, John S ^e   Cruchaga, Carlos ⁱ   Bras, Jose ^a   Goate, Alison M ^j   Singleton, Andrew B ^b   Guerreiro, Rita ^a   Hardy, John ^a   Passmore, Peter ^k   Craig, David ^k   Johnston, Janet ^k   McGuinness, Bernadette ^k   Todd, Stephen ^k   Heun, Reinhard ^l   Kölsch, Heike ^m   Kehoe, Patrick G ⁿ   Hooper, Nigel M ^o   Vardy, Emma R L C ^p   Mann, David M ^q   Lowe, James ^h   David Smith, A ^r   Wilcock, Gordon ^r   Warden, Donald ^r   Holmes, Clive ^s   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e BRIGHAM YOUNG UNIVERSITY   (United States)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^l ROYAL DERBY HOSPITAL   (United Kingdom)

^m UNIVERSITY OF BONN   (Germany)

ⁿ UNIVERSITY OF BRISTOL   (United Kingdom)

^o UNIVERSITY OF LEEDS   (United Kingdom)

^p NEWCASTLE UNIVERSITY   (United Kingdom)

^q UNIVERSITY OF MANCHESTER   (United Kingdom)

^r UNIVERSITY OF OXFORD   (United Kingdom)

^s UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

A2M GENE; ACE GENE; ADAM10 GENE; ADAM17 GENE; ADAM9 GENE; ADULT; AGED; ALZHEIMER DISEASE; APBA1 GENE; APH1B GENE; APLP1 GENE; ARTICLE; BACE1 GENE; BACE2 GENE; COHORT ANALYSIS; CONTROLLED STUDY; CST3 GENE; CTSB GENE; CTSD GENE; DISEASE COURSE; ECE1 GENE; ECE2 GENE; EXOME; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; GPR3 GENE; HUMAN; IDE GENE; KLK6 GENE; LRP1 GENE; LRRTM3 GENE; LYZ GENE; MAJOR CLINICAL STUDY; MALE; MEP1B GENE; MME GENE; MMP3 GENE; NCSTN GENE; NORTH AMERICA; ONSET AGE; PATHOGENESIS; PLAT GENE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN TRANSPORT; PSENEN GENE; SORL1 PROTEIN; TTR GENE; UNITED KINGDOM; VERY ELDERLY; BIOLOGY; GENETICS; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; COMPUTATIONAL BIOLOGY; EXOME; HUMANS;

EID: 84974686165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150079     Document Type: Article

References (53)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002 Jul. 19;297(5580):353-6. PMID: 12130773
2. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb. 21;349(6311):704-6. PMID: 1671712
3. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun. 29;375(6534):754-60. PMID: 7596406
4. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995 Aug. 31;376(6543):775-8. PMID: 7651536
5. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009 Oct; 41(10):1088-93. doi: 10.1038/ng.440 PMID: 19734902
6. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009 Oct; 41(10):1094-9. doi: 10.1038/ng.439 PMID: 19734903
7. Seshadri S, Fitzpatrick AL, Ikram MA, De Stefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA J Am Med Assoc. 2010 May 12;303(18):1832-40.
8. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May; 43(5):429-35. doi: 10.1038/ng.803 PMID: 21460840
9. Naj AC, Jun. G, Beecham GW, Wang L-S, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41. doi: 10.1038/ng.801 PMID: 21460841
10. Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, et al. Genome-wide association study of Alzheimer's disease. Transl Psychiatry. 2012;2:e117. doi: 10.1038/tp. 2012.45 PMID: 22832961
11. Reitz C, Jun. G, Naj A, Rajbhandary R, Vardarajan BN, Wang L-S, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4, and the risk of late-onset Alzheimer disease in African Americans. JAMA J Am Med Assoc. 2013 Apr. 10;309(14):1483-92.
12. Lambert J-C, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013 Dec; 45(12):1452-8. doi: 10.1038/ng.2802 PMID: 24162737
13. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851 PMID: 23150934
14. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013 Jan 10;368(2):107-16. doi: 10. 1056/NEJMoa1211103 PMID: 23150908
15. Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, et al. The PSEN1, p. E318G variant increases the risk of Alzheimer's disease in APOE-ϵ4 carriers. PLoS Genet. 2013;9(8):e1003685. doi: 10.1371/journal.pgen. 1003685 PMID: 23990795
16. Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. NeurobiolAging. 2014 Jun. 16;
17. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol Zurich Switz. 2008 Apr; 18(2):240-52.
18. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron. 2001 Oct. 25;32(2):177-80. PMID: 11683988
19. Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014 Oct; 17(10):1418-28. doi: 10.1038/nn. 3801 PMID: 25174004
20. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai S-L, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010 May; 6(5):e1000952. doi: 10.1371/journal.pgen. 1000952 PMID: 20485568
21. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. BioinformaOxf Engl. 2009 Aug. 15;25(16):2078-9.
22. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010 Sep; 20(9):1297-303. doi: 10.1101/gr.107524.110 PMID: 20644199
23. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma Oxf Engl. 2009 Jul. 15;25(14):1754-60.
24. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010 Sep; 38(16):e164. doi: 10.1093/nar/gkq603 PMID: 20601685
25. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007 Feb; 39(2):168-77. PMID: 17220890
26. Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry. 2012 Sep; 17(9):875-9. doi: 10.1038/mp. 2012.15 PMID: 22472873
27. Liu G, Li F, Zhang S, Jiang Y, Ma G, Shang H, et al. Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer's disease susceptibility. Mol Neurobiol. 2014 Dec; 50(3):757-64. doi: 10.1007/s12035-014-8670-4 PMID: 24643655
28. Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet. 2015 Mar. 25;
29. Costa R, Gonçalves A, Saraiva MJ, Cardoso I. Transthyretin binding to A-Beta peptide-impact on A-Betafibrillogenesis and toxicity. FEBS Lett. 2008 Mar. 19;582(6):936-42. doi: 10.1016/j.febslet.2008. 02.034 PMID: 18295603
30. Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, et al. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol Aging. 2011 Feb; 32(2):249-56. doi: 10.1016/j.neurobiolaging.2009.02.014 PMID: 19328595
31. Choi SH, Leight SN, Lee VM-Y, Li T, Wong PC, Johnson JA, et al. Accelerated Abetadeposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci Off J Soc Neurosci. 2007 Jun. 27;27(26):7006-10.
32. Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, et al. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease. Brain Pathol Zurich Switz. 2009 Jan; 19(1):48-57.
33. Zou K, Maeda T, Watanabe A, Liu J, Liu S, Oba R, et al. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. J Biol Chem. 2009 Nov. 13;284(46):31914-20. doi: 10.1074/jbc. M109.011437 PMID: 19773553
34. Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem. 2001 Dec. 21;276(51):47863-8. PMID: 11604391
35. Hemming ML, Selkoe DJ. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem. 2005 Nov. 11;280(45):37644-50. PMID: 16154999
36. Yamazaki H, Bujo H, Kusunoki J, Seimiya K, Kanaki T, Morisaki N, et al. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem. 1996 Oct. 4;271(40):24761-8. PMID: 8798746
37. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting proteinrelated receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA. 2005 Sep. 20;102(38):13461-6. PMID: 16174740
38. Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, et al. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J NeurosciOff J Soc Neurosci. 2006 Feb. 1;26(5):1596-603.
39. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SHR, Riehle C, et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry. 2010 Jul; 15(7):756-66. doi: 10.1038/mp. 2008.141 PMID: 19125160
40. Miyashita A, Koike A, Jun. G, Wang L-S, Takahashi S, Matsubara E, et al. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PloSOne. 2013;8(4):e58618. doi: 10.1371/journal.pone.0058618 PMID: 23565137
41. Tan EK, Lee J, Chen CP, Teo YY, Zhao Y, Lee WL. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol Aging. 2009 Jul; 30(7):1048-51. PMID: 18063222
42. Lee JH, Cheng R, Schupf N, Manly J, Lantigua R, Stern Y, et al. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol. 2007 Apr; 64(4):501-6. PMID: 17420311
43. Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol. 2004 Aug; 61(8):1200-5. PMID: 15313836
44. Yu L, Chibnik LB, Srivastava GP, Pochet N, Yang J, Xu J, et al. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24. doi: 10.1001/jamaneurol.2014.3049 PMID: 25365775
45. Vardarajan BN, Zhang Y, Lee JH, Cheng R, Bohm C, Ghani M, et al. Coding mutations in SORL1 and Alzheimer disease. Ann Neurol. 2015 Feb; 77(2):215-27. doi: 10.1002/ana.24305 PMID: 25382023
46. Kanekiyo T, Liu C-C, Shinohara M, Li J, Bu G. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β. J Neurosci Off J Soc Neurosci. 2012 Nov. 14;32(46):16458-65.
47. Farrer LA, Bowirrat A, Friedland RP, Waraska K, Korczyn AD, Baldwin CT. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet. 2003 Feb. 15;12(4):415-22. PMID: 12566388
48. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (Berl). 2009 Jul; 118(1):115-30.
49. Rossi GP, Sacchetto A, Cesari M, Pessina AC. Interactions between endothelin-1 and the renin-angiotensin-aldosterone system. Cardiovasc Res. 1999 Aug. 1;43(2):300-7. PMID: 10536660
50. Nalivaevaa NN, Fisk L, Kochkina EG, Plesneva SA, Zhuravin IA, Babusikova E, et al. Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann N YAcad Sci. 2004 Dec; 1035:21-33. PMID: 15681798
51. Nalivaeva NN, Belyaev ND, Kerridge C, Turner AJ. Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease. Front Aging Neurosci. 2014;6:235. doi: 10.3389/fnagi.2014.00235 PMID: 25278875
52. Li L, Zhang X, Yang D, Luo G, Chen S, Le W. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging. 2009 Jul; 30(7):1091-8. PMID: 18063223
53. Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, et al. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PloSOne. 2011;6(4):e19229. doi: 10.1371/journal.pone.0019229 PMID: 21559427